I to nie Gibraltarowi, czy San Marino, a Wolfsburgowi - trzeciej sile Bundesligi. Polak wszedł w drugiej połowie przy stanie 0-1 i wyciągnał wynik na 5-1.

According to the New York Times, Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim for $55 million on the same day that Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing.